Use of Implantable Venous Port Systems in the Treatment of Children with Orphan Diseases (Mucopolysaccharidosis and Pompe Disease): Case Series

• Main Authors: M. Yu. Rykov (Author), I. V. Filinov (Author), E. I. Petrov (Author), N. D. Vashakmadze (Author), A. K. Gevorkyan (Author), E. N. Arkhipova (Author), I. V. Sil'nova (Author), E. N. Basargina (Author), N. V. Buchinskaya (Author), A. I. Ivanov (Author), E. A. Isupova (Author), M. M. Kostik (Author), N. A. Abramova (Author), O. V. Kalashnikova (Author), V. G. Chasnyk (Author), A. E. Aleksandrov (Author), D. A. Morozov (Author), V. G. Polyakov (Author)
• Format: Book
• Published: "Paediatrician" Publishers LLC, 2015-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Many orphan diseases in children require life-long and regular intravenous enzyme replacement therapy. The article describes the first Russian practice of implanting venous port systems in 12 patients with type I and II mucopolysaccharidosis and Pompe disease (6 months to 17 years old) to create lon...